Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study

BACKGROUND: Neuroblastoma is the most common extra-cranial solid tumor among children. Despite intensive treatment, patients with advanced disease mostly experience dismal outcomes. Here, we proposed the use of topotecan and cyclophosphamide containing induction regimen as an upfront therapy to high...

Descripción completa

Detalles Bibliográficos
Autores principales: Rujkijyanont, Piya, Photia, Apichat, Traivaree, Chanchai, Monsereenusorn, Chalinee, Anurathapan, Usanarat, Seksarn, Panya, Sosothikul, Darintr, Techavichit, Piti, Sanpakit, Kleebsabai, Phuakpet, Kamon, Wiangnon, Surapon, Chotsampancharoen, Thirachit, Chainansamit, Su-on, Kanjanapongkul, Somjai, Meekaewkunchorn, Arunotai, Hongeng, Suradej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796460/
https://www.ncbi.nlm.nih.gov/pubmed/31619207
http://dx.doi.org/10.1186/s12885-019-6186-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796460/
https://www.ncbi.nlm.nih.gov/pubmed/31619207
http://dx.doi.org/10.1186/s12885-019-6186-z

Ejemplares similares